AAAAAA

   
Results: 1-16 |
Results: 16
BEAM-CELL TRANSPLANTATION IN MALIGNANT-LYMPHOMA - 100 CONSECUTIVE TRANSPLANTS IN A SINGLE-CENTER - EFFICACY, TOXICITY AND ENGRAFTMENT IN RELATION TO STEM-CELL SOURCE AND PREVIOUS TREATMENT(AUTOLOGOUS STEM)
Authors: GEISLER CH HANSEN MM ANDERSEN NS BROWN P CHRISTENSEN LD DICKMEISS E ERSBOLL J MYHRE J HANSEN M JUHL BR MORTENSEN BT PEDERSENBJERGAARD J
Citation: Ch. Geisler et al., BEAM-CELL TRANSPLANTATION IN MALIGNANT-LYMPHOMA - 100 CONSECUTIVE TRANSPLANTS IN A SINGLE-CENTER - EFFICACY, TOXICITY AND ENGRAFTMENT IN RELATION TO STEM-CELL SOURCE AND PREVIOUS TREATMENT(AUTOLOGOUS STEM), European journal of haematology, 61(3), 1998, pp. 173-182
IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA CHROMOSOME-17 ABNORMALITIES AND NOT TRISOMY-12 ARE THE SINGLE MOST IMPORTANT CYTOGENETIC ABNORMALITIES FOR THE PROGNOSIS - A CYTOGENETIC AND IMMUNOPHENOTYPIC STUDY OF 480UNSELECTED NEWLY-DIAGNOSED PATIENTS
Authors: GEISLER CH PHILIP P CHRISTENSEN BE HOUJENSEN K PEDERSEN NT JENSEN OM THORLING K ANDERSEN E BIRGENS HS DRIVSHOLM A ELLEGAARD J LARSEN JK PLESNER T BROWN P ANDERSEN PK HANSEN MM
Citation: Ch. Geisler et al., IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA CHROMOSOME-17 ABNORMALITIES AND NOT TRISOMY-12 ARE THE SINGLE MOST IMPORTANT CYTOGENETIC ABNORMALITIES FOR THE PROGNOSIS - A CYTOGENETIC AND IMMUNOPHENOTYPIC STUDY OF 480UNSELECTED NEWLY-DIAGNOSED PATIENTS, Leukemia research, 21(11-12), 1997, pp. 1011-1023
THE PROGNOSTIC-SIGNIFICANCE OF CHROMOSOMAL ANALYSIS AND IMMUNOPHENOTYPING IN 117 PATIENTS WITH DE-NOVO ACUTE MYELOID-LEUKEMIA
Authors: BROWN PD JURLANDER J PEDERSENBJERGAARD J VICTOR MA GEISLER CH
Citation: Pd. Brown et al., THE PROGNOSTIC-SIGNIFICANCE OF CHROMOSOMAL ANALYSIS AND IMMUNOPHENOTYPING IN 117 PATIENTS WITH DE-NOVO ACUTE MYELOID-LEUKEMIA, Leukemia research, 21(10), 1997, pp. 985-995
IN B-CLL, CHLORAMBUCIL AND CHOP GIVE EQUAL SURVIVAL AND CHROMOSOME-17ABNORMALITIES IS THE SINGLE MOST IMPORTANT FACTOR FOR THE OUTCOME OF TREATMENT - A CYTOGENETIC, IMMUNOPHENOTYPIC AND BONE-MARROW HISTOLOGICAL STUDY OF 175 CONSECUTIVE NEWLY-DIAGNOSED PATIENTS RANDOMIZED TO EITHER CHOP OR CHLORAMBUCIL PLUS PREDNISOLONE
Authors: GEISLER CH HANSEN MM PHILIP P CHRISTENSEN BE HOUJENSEN K TINGGAARDPEDERSEN N JENSEN OM THORLING K ANDERSEN E HANSEN NE NIELSEN H NIELSEN JB ELLEGAARD J LARSEN JK BROWN P ANDERSEN PK
Citation: Ch. Geisler et al., IN B-CLL, CHLORAMBUCIL AND CHOP GIVE EQUAL SURVIVAL AND CHROMOSOME-17ABNORMALITIES IS THE SINGLE MOST IMPORTANT FACTOR FOR THE OUTCOME OF TREATMENT - A CYTOGENETIC, IMMUNOPHENOTYPIC AND BONE-MARROW HISTOLOGICAL STUDY OF 175 CONSECUTIVE NEWLY-DIAGNOSED PATIENTS RANDOMIZED TO EITHER CHOP OR CHLORAMBUCIL PLUS PREDNISOLONE, Blood, 90(10), 1997, pp. 2358-2358
CHARACTERIZATION OF INTERLEUKIN-10 RECEPTOR EXPRESSION ON B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS
Authors: JURLANDER J LAI CF TAN J CHOU CC GEISLER CH SCHRIBER J BLUMENSON LE NARULA SK BAUMANN H CALIGIURI MA
Citation: J. Jurlander et al., CHARACTERIZATION OF INTERLEUKIN-10 RECEPTOR EXPRESSION ON B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS, Blood, 89(11), 1997, pp. 4146-4152
THE BONE-MARROW INFILTRATION PATTERN IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA IS NOT AN IMPORTANT PROGNOSTIC FACTOR
Authors: GEISLER CH HOUJENSEN K JENSEN OM TINGGARDPEDERSEN N HANSEN MM HANSEN NE HOLM M CHRISTENSEN BE DRIVSHOLM A NIELSEN JB THORLING K ANDERSEN E
Citation: Ch. Geisler et al., THE BONE-MARROW INFILTRATION PATTERN IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA IS NOT AN IMPORTANT PROGNOSTIC FACTOR, European journal of haematology, 57(4), 1996, pp. 292-300
CELL-CYCLE RECRUITMENT BY INTERLEUKIN-6 FOLLOWED BY CHEMOTHERAPY IN PATIENTS WITH B-CHRONIC LYMPHOCYTIC-LEUKEMIA AND NON-HODGKINS-LYMPHOMA
Authors: BROWN PN GEISLER CH MORTENSEN BT NISSEN NI
Citation: Pn. Brown et al., CELL-CYCLE RECRUITMENT BY INTERLEUKIN-6 FOLLOWED BY CHEMOTHERAPY IN PATIENTS WITH B-CHRONIC LYMPHOCYTIC-LEUKEMIA AND NON-HODGKINS-LYMPHOMA, Blood, 88(10), 1996, pp. 3490-3490
TRISOMY-12 IS FOUND IN CLL WITH BOTH TYPICAL AND ATYPICAL IMMUNOPHENOTYPE AND HAS NO PROGNOSTIC-SIGNIFICANCE - A CYTOGENETIC AND IMMUNOPHENOTYPIC STUDY OF 480 UNSELECTED NEWLY-DIAGNOSED PATIENTS
Authors: GEISLER CH PHILIP P CHRISTENSEN BE HOUJENSEN K PEDERSEN NT JENSEN OM THORLING K ANDERSEN E HANSEN NE NIELSEN H ELLEGAARD J LARSEN JK BROWN P ANDERSEN PK HANSEN MM
Citation: Ch. Geisler et al., TRISOMY-12 IS FOUND IN CLL WITH BOTH TYPICAL AND ATYPICAL IMMUNOPHENOTYPE AND HAS NO PROGNOSTIC-SIGNIFICANCE - A CYTOGENETIC AND IMMUNOPHENOTYPIC STUDY OF 480 UNSELECTED NEWLY-DIAGNOSED PATIENTS, Blood, 88(10), 1996, pp. 937-937
IMPROVED VACCINATION RESPONSE DURING RANITIDINE TREATMENT, AND INCREASED PLASMA HISTAMINE CONCENTRATIONS, IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: JURLANDER J BROWN PD SKOV PS HENRICHSEN J HERON I OBEL N MORTENSEN BT HANSEN MM GEISLER CH NIELSEN HJ
Citation: J. Jurlander et al., IMPROVED VACCINATION RESPONSE DURING RANITIDINE TREATMENT, AND INCREASED PLASMA HISTAMINE CONCENTRATIONS, IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia, 9(11), 1995, pp. 1902-1909
INTERLEUKIN-10 (IL-10) IS A SURVIVAL FACTOR FOR B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
Authors: JURLANDER J LAU CF TAN J CHOU CC GEISLER CH NARULA SK BAUMANN H CALIGIURI MA
Citation: J. Jurlander et al., INTERLEUKIN-10 (IL-10) IS A SURVIVAL FACTOR FOR B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL), Blood, 86(10), 1995, pp. 1371-1371
RISK OF KIDNEY CANCER AND OTHER 2ND SOLID MALIGNANCIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: MELLEMGAARD A GEISLER CH STORM HH
Citation: A. Mellemgaard et al., RISK OF KIDNEY CANCER AND OTHER 2ND SOLID MALIGNANCIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA, European journal of haematology, 53(4), 1994, pp. 218-222
TREATMENT OF HYPOGAMMAGLOBULINEMIA IN CHRONIC LYMPHOCYTIC-LEUKEMIA BYLOW-DOSE INTRAVENOUS GAMMA-GLOBULIN
Authors: JURLANDER J GEISLER CH HANSEN MM
Citation: J. Jurlander et al., TREATMENT OF HYPOGAMMAGLOBULINEMIA IN CHRONIC LYMPHOCYTIC-LEUKEMIA BYLOW-DOSE INTRAVENOUS GAMMA-GLOBULIN, European journal of haematology, 53(2), 1994, pp. 114-118
CHRONIC LYMPHOCYTIC-LEUKEMIA PATIENTS HAVE INCREASED PLASMA HISTAMINELEVELS, AND IMPROVES THEIR VACCINATION RESPONSE DURING RANITIDINE TREATMENT
Authors: JURLANDER J BROWN PD SKOV PS HENRICHSEN J HERON I OBEL N MORTENSEN BT HANSEN MM GEISLER CH NIELSEN J
Citation: J. Jurlander et al., CHRONIC LYMPHOCYTIC-LEUKEMIA PATIENTS HAVE INCREASED PLASMA HISTAMINELEVELS, AND IMPROVES THEIR VACCINATION RESPONSE DURING RANITIDINE TREATMENT, Blood, 84(10), 1994, pp. 10000461-10000461
THE BONE-MARROW INFILTRATION PATTERN IN CD5-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA HAS NO INDEPENDENT PROGNOSTIC-SIGNIFICANCE( B)
Authors: GEISLER CH HOUJENSEN K JENSEN OM TINGGAARDPEDERSEN N HANSEN MM HANSEN NE HOLM M CHRISTENSEN BE DRIVSHOLM A NIELSEN JB THORLING K ANDERSEN E LARSEN JK ANDERSEN PK
Citation: Ch. Geisler et al., THE BONE-MARROW INFILTRATION PATTERN IN CD5-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA HAS NO INDEPENDENT PROGNOSTIC-SIGNIFICANCE( B), Blood, 84(10), 1994, pp. 10000525-10000525
TREATMENT WITH CAMPATH-1H ANTIBODY IN PATIENTS WITH RELAPSED NON-HODGKIN-LYMPHOMA AND CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: BROWN PD GEISLER CH NISSEN NI
Citation: Pd. Brown et al., TREATMENT WITH CAMPATH-1H ANTIBODY IN PATIENTS WITH RELAPSED NON-HODGKIN-LYMPHOMA AND CHRONIC LYMPHOCYTIC-LEUKEMIA, Blood, 84(10), 1994, pp. 10000653-10000653
CHRONIC LYMPHOCYTIC-LEUKEMIA - NEWER PROGNOSTIC APPROACHES IN RELATION TO CLINICAL STAGE
Authors: GEISLER CH
Citation: Ch. Geisler, CHRONIC LYMPHOCYTIC-LEUKEMIA - NEWER PROGNOSTIC APPROACHES IN RELATION TO CLINICAL STAGE, Danish medical bulletin, 40(2), 1993, pp. 190-207
Risultati: 1-16 |